United States to India: Extract Import Trade Route

The United States to India Extract corridor is one of India's established pharmaceutical import routes from United States, with 16 shipments documented worth a combined $1.1K USD. The route is dominated by CELL SIGNALING TECHNOLOGY, which alone accounts for roughly 65% of all import value, reflecting the consolidated nature of United States's extract export sector.

Across 4 active United States suppliers, the average shipment value stands at $70 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with extract's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #18 among India's top extract import origins globally.

On the Indian buyer side, key Indian importers include IMPERIAL LIFE SCIENCES PVT LTD, AIC ENTERPRISES PRIVATE LIMITED, IMPERIAL LIFE SCIENCES PRIVATE LIMITED and 3 others. IMPERIAL LIFE SCIENCES PVT LTD is the single largest Indian importer with 4 shipments valued at $410 USD.

India's extract imports from United States are driven primarily by a handful of large-scale United States manufacturers. CELL SIGNALING TECHNOLOGY with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CELL SIGNALING TECHNOLOGY, R&D SYSTEMS INC, MIKART LLC — together account for 99% of total trade value on this route. The average shipment value of $70 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as spak/jnk control cell extracts part no. 9253s (antibody for invitro research use only) (free of cost) and lc3 control cell extracts part no. 11972s (antibody for invitro research use only) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States supplier.

On the buying side, IMPERIAL LIFE SCIENCES PVT LTD is the largest importer with 4 shipments worth $410 USD — representing 36% of all extract imports from United States on this route. A total of 6 buyers are active on this corridor.